Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000494:pharmacology; D000747:Anemia, Hypochromic / Q000652:urine; D001803:Blood Transfusion; D003676:Deferoxamine / Q000008:administration & dosage / Q000378:metabolism*; D004032:Diet; D004912:Erythrocytes / Q000378:metabolism; D005243:Feces / Q000032:analysis; D005260:Female; D006418:Heme / Q000378:metabolism; D006432:Hemochromatosis / Q000652:urine; D006461:Hemolysis / Q000187:drug effects; D006486:Hemosiderosis / Q000652:urine; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007408:Intestinal Absorption / Q000187:drug effects; D007501:Iron / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000378:metabolism* / Q000652:urine; D007503:Iron Isotopes; D007505:Iron-Dextran Complex / Q000494:pharmacology; D007668:Kidney / Q000502:physiology; D008297:Male; D008722:Methods; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology; D012737:Sex Factors; D013997:Time Factors; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D007502:Iron Chelating Agents; D007503:Iron Isotopes; D009539:Nicotinic Acids; D006418:Heme; D000493:Allopurinol; D007505:Iron-Dextran Complex; D007501:Iron; D014969:Xanthine Oxidase; D003676:Deferoxamine